Skip to main content
Top
Published in: European Archives of Oto-Rhino-Laryngology 11/2010

Open Access 01-11-2010 | Editorial

The real additional value of FDG-PET in detecting the occult primary tumour in patients with cervical lymph node metastases of unknown primary tumour

Author: Remco de Bree

Published in: European Archives of Oto-Rhino-Laryngology | Issue 11/2010

Login to get access

Excerpt

Cervical lymph node metastases may be the first manifestation of cancer. In some patients presenting with a cervical lymph node metastasis, the primary tumour remains elusive after extensive diagnostic work-up. In such cases, the patient is classified as having a so-called unknown primary tumour (UPT). The incidence of UPT ranges from 3 to 7% of all head and neck cancers. The most commonly histological diagnosis is squamous cell carcinoma (SCC). In case of SCC, the following diagnostic procedures are performed: physical head and neck examination at the outpatient clinic, CT or MRI of the head and neck area, X-ray or CT of the chest, and endoscopy under general anaesthesia of the whole upper aerodigestive tract (panendoscopy). During the panendoscopy, directed biopsies are taken from the nasopharynx, the base of the tongue and the tonsils (or tonsillectomy). Unfortunately, the yield of these directed biopsies taken during panendoscopy is low. Consequently, a substantial number of UPTs remains undetected with the conventional diagnostic procedures. In case of UPT, treatment mostly consists of a (modified) radical neck dissection in combination with irradiation of the whole pharyngeal axis. The irradiation of this large surface area aims the elimination of a probably very small (at least undetectable) malignant primary tumour. Unfortunately, this radiation treatment may cause considerable iatrogenic morbidity, e.g. mucositis, xerostomia, mucosal atrophy and even osteoradionecrosis. …
Literature
1.
go back to reference Rusthoven KE, Koshy M, Paulino AC (2004) The role of fuorodeoxyglucose positron emission tomography in cervical lymph nodes metastases from unknown primary tumor. Cancer 101:2642–2649CrossRef Rusthoven KE, Koshy M, Paulino AC (2004) The role of fuorodeoxyglucose positron emission tomography in cervical lymph nodes metastases from unknown primary tumor. Cancer 101:2642–2649CrossRef
2.
go back to reference Padovani D, Aimoni C, Zucchetta P, Paluzzi A, Pastore A (2009) 18-FDG PET in the diagnosis of laterocervical metastases from occult carcinoma. Eur Arch Otorhinolaryngol 266:267–271CrossRefPubMed Padovani D, Aimoni C, Zucchetta P, Paluzzi A, Pastore A (2009) 18-FDG PET in the diagnosis of laterocervical metastases from occult carcinoma. Eur Arch Otorhinolaryngol 266:267–271CrossRefPubMed
3.
go back to reference Yabuki K, Tsukuda M, Horiuchi C, Taguchi T, Nishimura G (2010) Role of 18F-FDG PET in detecting primary site in the patient with primary unknown carcinoma. Eur Arch Otorhinolaryngol. doi:10.1007/s00405-010-1371-3 PubMed Yabuki K, Tsukuda M, Horiuchi C, Taguchi T, Nishimura G (2010) Role of 18F-FDG PET in detecting primary site in the patient with primary unknown carcinoma. Eur Arch Otorhinolaryngol. doi:10.​1007/​s00405-010-1371-3 PubMed
4.
go back to reference Regelink G, Brouwer J, De Bree R et al (2002) Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities. Eur J Nucl Med 29:1024–1030CrossRef Regelink G, Brouwer J, De Bree R et al (2002) Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities. Eur J Nucl Med 29:1024–1030CrossRef
5.
go back to reference Burrel SC, Van den Abbeele AD (2005) 2-Deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography of the head and neck: an atlas of normal uptake and variants. Mol Imaging Biol 7:244–256CrossRef Burrel SC, Van den Abbeele AD (2005) 2-Deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography of the head and neck: an atlas of normal uptake and variants. Mol Imaging Biol 7:244–256CrossRef
6.
go back to reference Miller FR, Karnad AB, Eng T, Hussey DH, Stan McGuff H, Otto RA (2008) Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy. Head Neck 30:28–34CrossRefPubMed Miller FR, Karnad AB, Eng T, Hussey DH, Stan McGuff H, Otto RA (2008) Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy. Head Neck 30:28–34CrossRefPubMed
7.
go back to reference Boellaard R (2009) Standards for PET image acquisition and quantitative data analysis. J Nucl Med 50:11s–20sCrossRefPubMed Boellaard R (2009) Standards for PET image acquisition and quantitative data analysis. J Nucl Med 50:11s–20sCrossRefPubMed
8.
go back to reference Senft A, de Bree R, Hoekstra OS et al (2008) Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: a prospective multicenter trial study. Radiother Oncol 87:221–229CrossRefPubMed Senft A, de Bree R, Hoekstra OS et al (2008) Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: a prospective multicenter trial study. Radiother Oncol 87:221–229CrossRefPubMed
Metadata
Title
The real additional value of FDG-PET in detecting the occult primary tumour in patients with cervical lymph node metastases of unknown primary tumour
Author
Remco de Bree
Publication date
01-11-2010
Publisher
Springer-Verlag
Published in
European Archives of Oto-Rhino-Laryngology / Issue 11/2010
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-010-1372-2

Other articles of this Issue 11/2010

European Archives of Oto-Rhino-Laryngology 11/2010 Go to the issue